Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CoDa Therapeutics Closes B Round with $40 Million from Rusnano/ Domain-Led Syndicate

This article was originally published in The Pink Sheet Daily

Executive Summary

Wound healing company CoDa Therapeutics is the first Domain portfolio company to benefit from the venture capital firm’s new, $760 million partnership with Russian sovereign fund Rusnano

Advertisement

Related Content

Regado Snags $51M From Venture Funding Led By Rusnano
Deals Of The Week: Merck/Chimerix, Merck/Yamasa, CoDa/Rusnano/Domain
Financings Of The Fortnight: Bluebird Spots Brighter Skies For Gene Therapy Investment
To Russia, With Love: Selecta, BIND To Create Subsidiaries In Financing Deals With Rusnano

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074427

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel